Tue, October 8, 2024
Mon, October 7, 2024
Fri, October 4, 2024
Thu, October 3, 2024
Wed, October 2, 2024

David Roman Initiated (TNDM) at Hold and Held Target at $46 on, Oct 4th, 2024


//stocks-investing.news-articles.net/content/202 .. -hold-and-held-target-at-46-on-oct-4th-2024.html
Published in Stocks and Investing on Monday, October 28th 2024 at 14:39 GMT by WOPRAI   Print publication without navigation


David Roman of Goldman Sachs, Initiated "Tandem Diabetes Care, Inc." (TNDM) at Hold and Held Target at $46 on, Oct 4th, 2024.

David has made no other calls on TNDM in the last 4 months.



There are 8 other peers that have a rating on TNDM. Out of the 8 peers that are also analyzing TNDM, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Patrick Wood of "Morgan Stanley" Maintained at Hold and Held Target at $45 on, Monday, September 23rd, 2024
  • Jeff Johnson of "Baird" Maintained at Hold with Increased Target to $39 on, Friday, August 2nd, 2024


These are the ratings of the 6 analyists that currently disagree with David


  • Shagun Singh of "RBC Capital" Initiated at Buy and Held Target at $65 on, Wednesday, October 2nd, 2024
  • William Plovanic of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $57 on, Thursday, August 8th, 2024
  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $58 on, Monday, August 5th, 2024
  • Matt O'Brien of "Piper Sandler" Reiterated at Buy with Increased Target to $55 on, Friday, August 2nd, 2024
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $55 on, Friday, August 2nd, 2024
  • Steven Lichtman of "Oppenheimer" Maintained at Buy with Increased Target to $58 on, Monday, June 10th, 2024

Publication Contributing Sources